De Facto Comms

De Facto is a full-service agency with an international reach providing specialist communications consulting to the healthcare and life science sectors.

[De Facto Comms @DeFactoComms]

Not sure how, but #BIO2019 is topping even last year. The buzz around Philly is amazing!

[WuXi AppTec @WuXi_AppTec]

#ItStartsWithOne but the partnerships being formed at #BIO2019 will drive forward future innovation. Keep up good work,2 days to go @BIOConvention. Special thanks to everyone that came to the WuXi Reception at the astounding @TheFranklin Institute. Together we make a difference💪

[De Facto Comms @DeFactoComms]

@WuXi_AppTec @BIOTECanada congrats, it's really an amazing line-up again this year! https://t.co/bvzUUWkxdw And expecting big, big things from @BIOTECanada in 2019 and the next 5 year's: https://t.co/QNdjiigS98

[De Facto Comms @DeFactoComms]

A charity biotech - but it's about time someone prioritised these diseases areas https://t.co/W0wTsHPTer

[Forbes Health @forbeshealth]

Bill and Melinda Gates have started a nonprofit biotech in Boston to develop new medicines and vaccines for malaria, tuberculosis, and diarrhea https://t.co/rNsWz0jepX by @matthewherper

[John Carroll @JohnCendpts]

Hats off to #BIO18 -- Been coming for most of the last 15 years, and I've never seen this level of buzz about business, doing things, in #biotech. Congrats on a job well done.
@JMaraganore

[WuXi AppTec @WuXi_AppTec]

Last day of an amazing #BIO2018 – we bet some of you have great pics from last night’s epic @Dianaross concert! Send us a picture from this year's event to @WuXi_apptec to enter a not-for-profit research group you would like to support. @IAmBiotech @BIOConvention

[De Facto Comms @DeFactoComms]

If we were at #BIO2018 we would go with a human pyramid picture.... hmm probably more of a human pile knowing our coordination. well done @Dan5tanton for taking part @BIOConvention https://t.co/dRzFue1Mva

[WuXi AppTec @WuXi_AppTec]

#BIO2018 is for celebrating research & whilst we are all together, we will give $2000 to a medical research group you choose. Just Tweet @WuXi_AppTec a picture from BIO & your chosen non-profit name/handle. The most Likes and RT's wins. @IAmBiotech @BIOConvention #PICYourCharity

[De Facto Comms @DeFactoComms]

that's pretty outstanding growth for a mature company! https://t.co/6yLlzwgCoI

[Outsourcing-Pharma @OutsourcPharma]

.@AlmacGroup has reported a 19% growth in revenue to £531m ($709.86m) – a first for the company https://t.co/TJephJ7pWz

[WuXi AppTec @WuXi_AppTec]

Drum roll please 🥁

It's nearly here... no, not the weekend – #BIO2018!! Are you as excited as we are? Join us at booth number 963 – or catch us speaking at both our AI & China sessions. Let’s #MakeBIOHistory together! @BIOConvention

[De Facto Comms @DeFactoComms]

Amazing story - worth reading if you have not come across them... or even if you have! https://t.co/QAiyMGil7h

[WuXi AppTec @WuXi_AppTec]

Meet John Hood, CEO of Impact Biomedicines – which launched in the fall 2016 with a $22 million Series A, and then recently sold to Celgene for $7 billion – on 'how passion, dedication & good #science revived a life-saving drug'. https://t.co/vFnssx7juV #biotech #entrepreneur

[De Facto Comms @DeFactoComms]

Patient centric research is the future of drug development🙌. patients have to have a 📣. quality of life is integral to treatment https://t.co/7Jv6s7QW3a

[WuXi AppTec @WuXi_AppTec]

Important statement on benefit-risk assessment from @SGottliebFDA. "Patients are, rightly so, becoming the driving force of the medical research enterprise". #patientengagement #patientcentric https://t.co/4CKvhrKOey

[WuXi AppTec @WuXi_AppTec]

Please remember tomorrow is @rarediseaseday 2018. We believe every drug can be made and every disease treated! But as an industry, we still have a long way to go. There are 7,000 rare conditions, but only 500 #FDA approved treatments. so lend your support https://t.co/VN4nrjqxQg

[De Facto Comms @DeFactoComms]

it's too late in the evening to be seeing this. jpm18 is done for the day for this UK viewer. https://t.co/mnvYOGHzd6

[John Nosta @JohnNosta]

Hey Sophia, who’s the dominate voice in #digitalhealth?#DigitalHealthCES #CES2018 #JPM18 @evankirstel #AI

[De Facto Comms @DeFactoComms]

Big insights from the #Wuxiglobalforum #jpm18 - innovation in China is not coming - it's here! https://t.co/a43PlDahEg https://t.co/epEDBPveMs

[C&EN (Chemical & Engineering News) @cenmag]

https://t.co/MNOGn6pQLH

[Melissa Fassbender @melfass]

As an ecosystem we all do very well when everyone in the industry is hitting on all cylinders, and that goes for geographies as well - Bruce Booth #WuXiGlobalForum2018 #JPM18

[Lisa Jarvis @lisamjarvis]

When asked how Atlas makes such good bets, @LifeSciVC gets big laughs for “We are, like, really smart” #JPM18

[John Carroll @JohnCendpts]

If you see me in San Fran, remember it's #fistbump #JPM18 to cut down the spread of the flu. Handshakes are a vestige of an earlier, germ-ignorant culture. We can do better and still meet and greet in style. #fistbump is 1/20th as likely to spread flu -- there's a study!

[WuXi AppTec @WuXi_AppTec]

Ensure you don't miss the insights from the #WuXiGlobalForum at #JPM18. Register here to watch the live global webcast, 9th January 2018: https://t.co/iZJSKGLh0U – @bioweeksf @jpmorgan

[De Facto Comms @DeFactoComms]

#pharma needs a change, is it coming? How ironic that we need to innovate our way out of essentially an R&D productivity crisis. it's an existential crisis 30-years in the making. https://t.co/6bGeUAivPk

[John Carroll @JohnCendpts]

This column, which I have dubbed Nightmare on Pharma Street, went semi-viral yesterday.
https://t.co/iRtgyXOaop

[De Facto Comms @DeFactoComms]

To continue the lift off theme, these biotechs really are making one big leap for mankind! https://t.co/52QzsvvzTE

[WuXi AppTec @WuXi_AppTec]

We have takeoff - the 'LaunchPad' session at #WuXiGlobalForum, #JPM18 explores new disruptive therapeutic interventions taking the industry to new highs. Tango Therapeutics, @SangamoTx @KaleidoBio @Novocure @IAmBiotech https://t.co/fKRXOyNRzr

[WuXi AppTec @WuXi_AppTec]

Our 'Betting On The Best' session at #JPM18 will see Jay Bradner, Rupert Vessey, Bruce Booth, and Edward Hu share perspectives on pushing the boundaries of innovation, and what’s coming next for the industry. @LifeSciVC @jaybradner @Novartis @Celgene – https://t.co/fKRXOyNRzr